4/A

PRIMARY DOCUMENT

Company: BIOCRYST PHARMACEUTICALS INC
Filed: April 12, 2013
Period of Report: January 1, 2013
Accession Number: 0001127602-13-013812

View Document ↗ View on SEC.gov ↗